2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

about

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

Item

http://www.wikidata.org/entity/Q57136607

description

scientific article published on 25 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@en

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@nl

type

Item

label

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@en

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@nl

prefLabel

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@en

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@nl

P1476

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism

@en

P2093

George J Kahaly

http://www.w3.org/2001/XMLSchema#string

Kris Poppe

http://www.w3.org/2001/XMLSchema#string

Laurence Leenhardt

http://www.w3.org/2001/XMLSchema#string

Lazlo Hegedüs

http://www.w3.org/2001/XMLSchema#string

Luigi Bartalena

http://www.w3.org/2001/XMLSchema#string

P2860

What Is the Best Definitive Treatment for Graves’ Disease? A Systematic Review of the Existing Literature

Antithyroid drug regimen for treating Graves' hyperthyroidism

Radioiodine treatment for pediatric Graves' disease

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease

Selenium and the course of mild Graves' orbitopathy

Life-threatening thyrotoxicosis. Thyroid storm

TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study

Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease

Graves' Disease.

Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.

P304

167-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000490384

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon Pearce

P577

2018-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30283735

http://www.w3.org/2001/XMLSchema#string

P932

6140607

http://www.w3.org/2001/XMLSchema#string